Author Schanz, Julie
-
2006 | Conference Abstract
New and comprehensive cytogenetic prognostication and categorization in MDS.
Haase, D.; Germing, U.; Schanz, J.; Pfeilstoecker, M.; Noesslinger, T.; Hildebrandt, B. & Kuendgen, A. et al. (2006)
Blood, 108(11) 48th Annual Meeting of the American-Society-of-Hematology, Orlando, FL.
Washington: Amer Soc Hematology.
Details WoS
-
2006 | Conference Abstract
Evidence for an underestimation of the prognostic impact of poor cytogenetics within the IPSS.
Haase, D.; Germing, U.; Schanz, J.; Pfeilstoecker, M.; Hildebrandt, B.; Luebbert, M. & Giagounidis, A. A. N. et al. (2006)
Blood, 108(11) , Orlando, FL.
Washington: Amer Soc Hematology.
Details WoS
-
2007 | Conference Abstract
FISH-Analyses of cirulating CD34+cells in MDS-Patients - A suitable method to measure and predict response to 5-azacytidinie.
Braulke, F.; Schanz, J.; Steidl, C.; Truemper, L. H. & Haase, D. (2007)
Blood, 110(11) pp. 727A-728A. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA.
Washington: Amer Soc Hematology.
Details WoS
-
2007 | Journal Article
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients
Haase, D.; Germing, U.; Schanz, J.; Pfeilstoecker, M.; Noesslinger, T.; Hildebrandt, B. & Kundgen, A. et al. (2007)
Blood, 110(13) pp. 4385-4395. DOI: https://doi.org/10.1182/blood-2007-03-082404
Details DOI PMID PMC WoS
-
2008 | Conference Abstract
New Prognostic Data on Rare Cytogenetic Abnormalities in MDS: A Collaborative Study of the International Working Group on MDS Cytogenetics.
Schanz, J.; Slovak, M. L.; Ohyashiki, K.; Sole, F.; del Mar Mallo, M.; Steidl, C. & Pfeilstoecker, M. et al. (2008)
Blood, 112(11) pp. 929-930. 50th Annual Meeting of the American-Society-of-Hematology, San Francisco, CA.
Washington: Amer Soc Hematology.
Details WoS
-
2008 | Conference Abstract
Analysing Circulating CD34+Cells by FISH Is Representative for the Clone Size in Bone Marrow in MDS Patients Under Different Therapy Modalities.
Braulke, F.; Schanz, J.; Truemper, L. H. & Haase, D. (2008)
Blood, 112(11) pp. 932-933. 50th Annual Meeting of the American-Society-of-Hematology, San Francisco, CA.
Washington: Amer Soc Hematology.
Details WoS
-
2008 | Conference Abstract
Prognostic Impact of Additional Chromosomal Aberrations (ACA) to 5q-in Patients with primary Myelodysplastic Syndrome
Del Mar Mallo, M.; Cervera, J.; Schanz, J.; Espinet, B.; Such, E.; Luno, E. & Steidl, C. et al. (2008)
Blood, 112(11) 50th Annual Meeting of the American-Society-of-Hematology/ASH/ASCO Joint Symposium, San Francisco, CA.
Washington: Amer Soc Hematology.
Details WoS
-
2009 | Conference Abstract
Cytogenetic Risk Features in MDS-Update and Present State.
Schanz, J.; Tuechler, H.; Sole, F.; Mallo, M.; Hildebrandt, B.; Slovak, M. L. & Ohyashiki, K. et al. (2009)
Blood, 114(22) 51st Annual Meeting of the American-Society-of-Hematology, New Orleans, LA.
Washington: Amer Soc Hematology.
Details WoS
-
2009 | Conference Abstract
Survival, Prognostic Factors, and Rates of Leukemic Transformation in a Multicenter Study of 303 Untreated Patients with MDS and Del(5q)
Germing, U.; Lauseker, M.; Hildebrandt, B.; Symeonidis, A.; Cermak, J.; Pfeilstoecker, M. & Noesslinger, T. et al. (2009)
Blood, 114(22) pp. 390-391. 51st Annual Meeting of the American-Society-of-Hematology, New Orleans, LA.
Washington: Amer Soc Hematology.
Details WoS
-
2009 | Journal Article
Amifostine has the potential to induce haematologic responses and decelerate disease progression in individual patients with low- and intermediate-1-risk myelodysplastic syndromes
Schanz, J.; Jung, H.; Woermann, B.; Gassmann, W.; Petersen, T.; Hinke, A. & Haase, D. (2009)
Leukemia Research, 33(9) pp. 1183-1188. DOI: https://doi.org/10.1016/j.leukres.2009.03.027
Details DOI PMID PMC WoS
-
2010 | Journal Article
FISH analysis of circulating CD34+cells as a new tool for genetic monitoring in MDS: Verification of the method and application to 27 MDS patients
Braulke, F.; Schanz, J.; Jung, K.; Shirneshan, K.; Schulte, K.; Schuetze, C. & Steffens, R. et al. (2010)
Leukemia Research, 34(10) pp. 1296-1301. DOI: https://doi.org/10.1016/j.leukres.2010.01.010
Details DOI PMID PMC WoS
-
2011 | Conference Abstract
Genetic Response to Lenalidomide in the Circulating Progenitor Cell Compartment of MDS Cohort. Preliminary Results of the Multicenter German LE-MON-5 Study
Shirneshan, K.; Germing, U.; Braulke, F.; Schanz, J.; Platzbecker, U.; Giagounidis, A. A. N. & Nolte, F. et al. (2011)
Blood, 118(21) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis, San Diego, CA.
Washington: Amer Soc Hematology.
Details WoS
-
2011 | Conference Abstract
Proof of Y-Loss As Clonal Abnormality in MDS by Comparative Analysis of CD34+and CD3+Peripheral Blood Cells
Ganster, C.; Braulke, F.; Shirneshan, K.; Kaempfe, D.; Platzbecker, U.; Soeling, U. & Bramlage, C. P. et al. (2011)
Blood, 118(21) pp. 1623-1624. , San Diego, CA.
Washington: Amer Soc Hematology.
Details WoS
-
2011 | Journal Article |
Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid
Kuendgen, A.; Bug, G.; Ottmann, O. G.; Haase, D.; Schanz, J.; Hildebrandt, B. & Nachtkamp, K. et al. (2011)
Clinical Epigenetics, 2 pp. 389-399. DOI: https://doi.org/10.1007/s13148-011-0031-9
Details DOI PMID PMC WoS
-
2011 | Journal Article
Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System
Schanz, J.; Steidl, C.; Fonatsch, C.; Pfeilstoecker, M.; Noesslinger, T.; Tuechler, H. & Valent, P. et al. (2011)
Journal of Clinical Oncology, 29(15) pp. 1963-1970. DOI: https://doi.org/10.1200/JCO.2010.28.3978
Details DOI PMID PMC WoS
-
2011 | Journal Article | Letter Note
Two different del(5q) clones in a patient with myelodysplastic syndrome
Braulke, F.; Schanz, J.; Steffens, R.; Liehr, T.; Manvelyan, M.; Chudoba, I. & Haase, D. (2011)
Leukemia & Lymphoma, 52(9) pp. 1811-1814. DOI: https://doi.org/10.3109/10428194.2011.575968
Details DOI PMID PMC WoS
-
2012 | Conference Abstract
A Comprehensive Genetic Analysis of MDS Patients From Peripheral Blood Combining FISH- and SNP-Array-Analysis
Ganster, C.; Shirneshan, K.; Salinas-Riester, G.; Braulke, F.; Schanz, J.; Goetze, K. S. & Bug, G. et al. (2012)
Blood, 120(21) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA.
Washington: Amer Soc Hematology.
Details WoS
-
2012 | Journal Article | Letter Note
Cytogenetic Risk Stratification in Myelodysplastic Syndromes: Are We There Yet? Reply
Schanz, J. & Haase, D. (2012)
Journal of Clinical Oncology, 30(21) pp. 2704-2706. DOI: https://doi.org/10.1200/JCO.2012.43.8267
Details DOI WoS
-
2012 | Journal Article
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Greenberg, P. L.; Tuechler, H.; Schanz, J.; Sanz, G. F.; Garcia-Manero, G.; Sole, F. & Bennett, J. M. et al. (2012)
Blood, 120(12) pp. 2454-2465. DOI: https://doi.org/10.1182/blood-2012-03-420489
Details DOI PMID PMC WoS
-
2012 | Journal Article
New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge
Schanz, J.; Tuechler, H.; Sole, F.; Mallo, M.; Luno, E.; Cervera, J. & Granada, I. et al. (2012)
Journal of Clinical Oncology, 30(8) pp. 820-829. DOI: https://doi.org/10.1200/JCO.2011.35.6394
Details DOI PMID PMC WoS